Tizanidine
- Product NDC
- 70934-268
- 11-digit product format
- 709340268
- Labeler code
- 70934
- Product ID
- 70934-268_b7b47e4f-1a38-179c-e053-2a95a90a8111
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2019-02-15
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-268-30 | 70934026830 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-268-30) | 30 tablet | 2019-02-15 | 0000-00-00 | No | No | Current |
| 70934-268-90 | 70934026890 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-268-90) | 90 tablet | 2019-04-01 | 0000-00-00 | No | No | Current |